CYRX Cryoport Inc

  1. Stocks
  2. Industrials
  3. NASDAQ: CYRX

Price (delayed)

$14.76

Market cap

$743.94M

P/E Ratio

11.01

Dividend/share

N/A

EPS

$1.34

Enterprise value

$699.47M

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 92
Relative Profitability: Rel. Profitability: 69

Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through ...

Highlights
Cryoport's equity has increased by 24% YoY
CYRX's gross profit is up by 18% year-on-year and by 3.9% since the previous quarter
The company's net income has surged by 171% YoY but it fell by 2.9% QoQ
Cryoport's EPS has soared by 157% YoY but it has decreased by 4.3% from the previous quarter
The price to earnings (P/E) is 64% higher than the last 4 quarters average of 6.7
The quick ratio has declined by 47% year-on-year and by 2.9% since the previous quarter
Sector: Industrials
Industry: Integrated Freight & Logistics
Website: http://www.cryoport.com
Peers: GEF VMI FRD

Key stats

What are the main financial stats of CYRX

CYRX stock price

How has the Cryoport stock price performed over time
Intraday
-0.07%
1 week
0.34%
1 month
5.43%
1 year
125%
YTD
53.75%
QTD
78.26%

Financial performance

How have Cryoport's revenue and profit performed over time
Revenue
$182.94M
Gross profit
$86.33M
Operating income
-$39.23M
Net income
$76.05M
Gross margin
47.2%
Net margin
41.6%
The company's net income has surged by 171% YoY but it fell by 2.9% QoQ
The net margin has soared by 162% YoY but it has decreased by 6% from the previous quarter
Cryoport's operating margin has surged by 69% YoY but it has decreased by 2.4% QoQ
Cryoport's operating income has soared by 65% YoY but it has decreased by 7% from the previous quarter

Price vs fundamentals

How does CYRX's price correlate with its fundamentals

Growth

What is Cryoport's growth rate over time

Valuation

What is Cryoport stock price valuation
P/E
11.01
P/B
1.49
P/S
4.03
EV/EBIT
8.75
EV/EBITDA
6.23
EV/Sales
3.82
Cryoport's EPS has soared by 157% YoY but it has decreased by 4.3% from the previous quarter
The price to earnings (P/E) is 64% higher than the last 4 quarters average of 6.7
CYRX's price to book (P/B) is 66% more than its last 4 quarters average of 0.9 but 22% less than its 5-year quarterly average of 1.9
Cryoport's equity has increased by 24% YoY
CYRX's P/S is 61% above its last 4 quarters average of 2.5 but 25% below its 5-year quarterly average of 5.4
The revenue rose by 14% year-on-year and by 3.8% since the previous quarter

Efficiency

How efficient is Cryoport business performance
Cryoport's ROS has soared by 167% YoY but it has decreased by 7% from the previous quarter
The return on assets has surged by 156% year-on-year but it has declined by 5% since the previous quarter
CYRX's return on equity has surged by 147% year-on-year but it is down by 8% since the previous quarter
The company's return on invested capital rose by 14% QoQ

Dividends

What is CYRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYRX.

Financial health

How did Cryoport financials performed over time
The total assets is 184% more than the total liabilities
The current ratio has plunged by 62% YoY and by 3.7% from the previous quarter
The quick ratio has declined by 47% year-on-year and by 2.9% since the previous quarter
The debt is 53% less than the equity
Cryoport's equity has increased by 24% YoY
The debt to equity has declined by 23% year-on-year but it is up by 2.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.